$REAL
TheRealReal, Inc. Stock $real

$real Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000157322124000030 Filed on March 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$143.8M	$143.4M	$549.3M
YoY Change	1.34%	-10.2%	-8.98%
Cost Of Revenue	$36.52M	$37.32M	$173.0M
YoY Change	-29.66%	-40.8%	-32.09%
Gross Profit	$107.3M	$106.0M	$376.3M
YoY Change	19.22%	9.77%	7.91%
Gross Profit Margin	74.6%	73.97%	68.5%
Selling, General & Admin	$46.77M	$119.7M	$182.5M
YoY Change	-6.17%	-11.04%	-6.51%
% of Gross Profit	43.6%	112.88%	48.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$8.309M	$8.165M	$31.70M
YoY Change	6.24%	10.13%	14.55%
% of Gross Profit	7.75%	7.7%	8.42%
Operating Expenses	$125.2M	$119.7M	$542.6M
YoY Change	-27.11%	-11.04%	0.88%
Operating Profit	-$17.94M	-$13.66M	-$166.3M
YoY Change	-78.07%	-64.01%	-12.09%
Interest Expense	$3.751M	-$595.0K	$10.70M
YoY Change	40.64%	-5.1%	2.19%
% of Operating Profit
Other Income/Expense, Net	-$15.58M	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Pretax Income	-$31.03M	-$21.66M	-$168.2M
YoY Change	-62.35%	-43.8%	-14.31%
Income Tax	$71.00K	$36.00K	$283.0K
% Of Pretax Income
Net Earnings	-$31.10M	-$21.69M	-$168.5M
YoY Change	-62.3%	-43.82%	-14.24%
Net Earnings / Revenue	-21.63%	-15.13%	-30.67%
Basic Earnings Per Share	-$0.30		-$1.65
Diluted Earnings Per Share	-$0.30	-$0.21	-$1.65
COMMON SHARES
Basic Shares Outstanding	104.7M shares	103.4M shares	101.8M shares
Diluted Shares Outstanding	105.2M shares		101.8M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$166.0M	$175.7M	$175.7M
YoY Change	-32.83%	-40.19%	-40.19%
Cash & Equivalents	$166.0M	$175.7M	$124.8M
Short-Term Investments
Other Short-Term Assets	$18.39M	$20.77M	$20.77M
YoY Change	-24.03%	-10.84%	-10.84%
Inventory	$21.12M	$22.25M	$22.25M
Prepaid Expenses
Receivables	$19.82M	$17.23M	$17.23M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$225.3M	$235.9M	$235.9M
YoY Change	-27.58%	-36.62%	-36.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$101.3M	$104.1M	$190.4M
YoY Change	-0.54%	-7.63%	-20.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.330M	$5.627M	$20.54M
YoY Change	68.67%	104.69%	647.22%
Total Long-Term Assets	$206.3M	$211.0M	$211.0M
YoY Change	2.81%	-13.32%	-13.32%
TOTAL ASSETS
Total Short-Term Assets	$225.3M	$235.9M	$235.9M
Total Long-Term Assets	$206.3M	$211.0M	$211.0M
Total Assets	$431.6M	$446.9M	$446.9M
YoY Change	-15.67%	-27.41%	-27.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.13M	$8.961M	$8.961M
YoY Change	59.31%	-24.71%	-24.71%
Accrued Expenses	$75.80M	$77.12M	$151.6M
YoY Change	5.11%	-5.42%	-19.17%
Deferred Revenue	$2.069M	$2.214M
YoY Change	-41.35%	-37.62%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$193.7M	$188.9M	$188.9M
YoY Change	5.3%	-8.99%	-8.99%
LONG-TERM LIABILITIES
Long-Term Debt	$433.5M	$452.4M	$452.4M
YoY Change	-3.76%	0.57%	0.57%
Other Long-Term Liabilities	$4.612M	$4.083M	$108.9M
YoY Change	39.88%	25.48%	-15.14%
Total Long-Term Liabilities	$4.612M	$4.083M	$561.4M
YoY Change	39.88%	25.48%	-2.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$193.7M	$188.9M	$188.9M
Total Long-Term Liabilities	$4.612M	$4.083M	$561.4M
Total Liabilities	$758.6M	$750.2M	$750.2M
YoY Change	0.44%	-4.52%	-4.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.151B	-$1.120B
YoY Change	11.33%	17.71%
Common Stock	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$327.1M	-$303.3M	-$303.3M
YoY Change
Total Liabilities & Shareholders Equity	$431.6M	$446.9M	$446.9M
YoY Change	-15.67%	-27.41%	-27.41%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$31.10M	-$21.69M	-$168.5M
YoY Change	-62.3%	-43.82%	-14.24%
Depreciation, Depletion And Amortization	$8.309M	$8.165M	$31.70M
YoY Change	6.24%	10.13%	14.55%
Cash From Operating Activities	-$3.467M	$10.52M	-$61.27M
YoY Change	-88.61%	184.56%	-33.08%
INVESTING ACTIVITIES
Capital Expenditures	$2.141M	$6.730M	$29.18M
YoY Change	-81.71%	-36.91%	27.63%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change
Cash From Investing Activities	-$5.321M	-$6.730M	-$42.13M
YoY Change	-66.58%	-36.91%	14.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$886.0K
YoY Change			-36.71%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$929.0K	262.0K	$226.0K
YoY Change	214.92%	-18.89%	-94.49%
NET CHANGE
Cash From Operating Activities	-$3.467M	10.52M	-$61.27M
Cash From Investing Activities	-$5.321M	-6.730M	-$42.13M
Cash From Financing Activities	-$929.0K	262.0K	$226.0K
Net Change In Cash	-$9.717M	4.055M	-$103.2M
YoY Change	-79.17%	-161.01%	-17.05%
FREE CASH FLOW
Cash From Operating Activities	-$3.467M	$10.52M	-$61.27M
Capital Expenditures	$2.141M	$6.730M	$29.18M
Free Cash Flow	-$5.608M	$3.793M	-$90.45M
YoY Change	-86.69%	-154.43%	-20.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	283000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-168472000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-196445000	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.05
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.58
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101806000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95921246	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91409624	shares
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29177000	usd
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3254000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	750222000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	785733000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	San Francisco, CA
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175709000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	293793000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17226000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12207000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	22246000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	42967000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20766000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	23291000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	235947000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	372258000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104087000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	112679000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	86348000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	127955000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	14914000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5627000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2749000	usd
CY2023Q4	us-gaap	Assets Assets	446923000	usd
CY2022Q4	us-gaap	Assets Assets	615641000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8961000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11902000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	77122000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	81543000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20094000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20776000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	82685000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	93292000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	188862000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	207513000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	104856000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	125118000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	452421000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	449848000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4083000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	104670500	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	104670500	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99088172	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99088172	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	816325000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	781060000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1119625000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-951153000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-303299000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-170092000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	446923000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	615641000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	549304000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	603493000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	467692000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	173026000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	254802000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	194215000	usd
CY2023	us-gaap	Gross Profit GrossProfit	376278000	usd
CY2022	us-gaap	Gross Profit GrossProfit	348691000	usd
CY2021	us-gaap	Gross Profit GrossProfit	273477000	usd
CY2023	us-gaap	Marketing Expense MarketingExpense	58275000	usd
CY2022	us-gaap	Marketing Expense MarketingExpense	62988000	usd
CY2021	us-gaap	Marketing Expense MarketingExpense	62749000	usd
CY2022	real	Operations And Technology Expense OperationsAndTechnologyExpense	278628000	usd
CY2021	real	Operations And Technology Expense OperationsAndTechnologyExpense	233687000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	176246000	usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1340000	usd
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	456000	usd
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	13389000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	537854000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	488385000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-214908000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	8805000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3191000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	365000	usd
CY2023	us-gaap	Interest Expense InterestExpense	10701000	usd
CY2022	us-gaap	Interest Expense InterestExpense	10472000	usd
CY2021	us-gaap	Interest Expense InterestExpense	21531000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	171000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-168189000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-196273000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-236051000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	172000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-236107000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.65
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.65
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.05
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.58
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101806000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95921246	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91409624	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-168472000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-196445000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-236107000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-11000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-168472000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-196445000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-236118000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	191293000	usd
CY2021	real	Stock Issued During Period Purchase Of Capped Calls Value StockIssuedDuringPeriodPurchaseOfCappedCallsValue	33666000	usd
CY2021	real	Equity Component Of Convertible Debt Issuance Costs EquityComponentOfConvertibleDebtIssuanceCosts	3131000	usd
CY2021	us-gaap	Adjustment To Additional Paid In Capital Convertible Debt Instrument Issued At Substantial Premium AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium	93031000	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2341000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	50246000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-236107000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	73128000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2906000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-216000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1400000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	47767000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-196445000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-170092000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-690000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	886000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35050000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-168472000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-303299000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-168472000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-196445000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31695000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	27669000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	34273000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	46138000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	947000	usd
CY2023	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	16746000	usd
CY2022	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	19602000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1962000	usd
CY2023	real	Accrued Interest On Convertible Notes AccruedInterestOnConvertibleNotes	0	usd
CY2022	real	Accrued Interest On Convertible Notes AccruedInterestOnConvertibleNotes	0	usd
CY2021	real	Accrued Interest On Convertible Notes AccruedInterestOnConvertibleNotes	950000	usd
CY2023	real	Gain Loss On Disposition Of Property Plant Equipment And Impairment Of Software GainLossOnDispositionOfPropertyPlantEquipmentAndImpairmentOfSoftware	-223000	usd
CY2022	real	Gain Loss On Disposition Of Property Plant Equipment And Impairment Of Software GainLossOnDispositionOfPropertyPlantEquipmentAndImpairmentOfSoftware	-702000	usd
CY2021	real	Gain Loss On Disposition Of Property Plant Equipment And Impairment Of Software GainLossOnDispositionOfPropertyPlantEquipmentAndImpairmentOfSoftware	-546000	usd
CY2023	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	2573000	usd
CY2022	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	2368000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	39739000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	9783000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	4077000	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	738000	usd
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2023	real	Amortization Of Premiums Discounts On Short Term Investments AmortizationOfPremiumsDiscountsOnShortTermInvestments	0	usd
CY2022	real	Amortization Of Premiums Discounts On Short Term Investments AmortizationOfPremiumsDiscountsOnShortTermInvestments	0	usd
CY2021	real	Amortization Of Premiums Discounts On Short Term Investments AmortizationOfPremiumsDiscountsOnShortTermInvestments	-10000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6981000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6120000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1588000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10938000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-23971000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29204000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2001000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2952000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4009000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	3050000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	409000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	638000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-26478000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-17764000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-15285000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-425000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4947000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-9989000	usd
CY2023	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	-4421000	usd
CY2022	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	10501000	usd
CY2021	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	13989000	usd
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-464000	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-9823000	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	30922000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-172000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	301000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-61268000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-91557000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-142151000	usd
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	usd
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	4000000	usd
CY2023	us-gaap	Payments For Software PaymentsForSoftware	12951000	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	14061000	usd
CY2021	us-gaap	Payments For Software PaymentsForSoftware	9967000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22861000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37470000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42128000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36922000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43437000	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	278234000	usd
CY2023	real	Payment For Purchase Of Capped Calls PaymentForPurchaseOfCappedCalls	0	usd
CY2022	real	Payment For Purchase Of Capped Calls PaymentForPurchaseOfCappedCalls	0	usd
CY2021	real	Payment For Purchase Of Capped Calls PaymentForPurchaseOfCappedCalls	33666000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2906000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	886000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1400000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2341000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	679000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	205000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	226000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4101000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	252913000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-103170000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-124378000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	67325000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293793000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	418171000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	350846000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190623000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293793000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	418171000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	8127000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	8104000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	6584000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	227000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	256000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	94000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1757000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	13860000	usd
CY2023	real	Purchases Of Capitalized Proprietary Software Development Costs Included In Accounts Payable And Other Accrued And Current Liabilities PurchasesOfCapitalizedProprietarySoftwareDevelopmentCostsIncludedInAccountsPayableAndOtherAccruedAndCurrentLiabilities	1122000	usd
CY2022	real	Purchases Of Capitalized Proprietary Software Development Costs Included In Accounts Payable And Other Accrued And Current Liabilities PurchasesOfCapitalizedProprietarySoftwareDevelopmentCostsIncludedInAccountsPayableAndOtherAccruedAndCurrentLiabilities	1590000	usd
CY2021	real	Purchases Of Capitalized Proprietary Software Development Costs Included In Accounts Payable And Other Accrued And Current Liabilities PurchasesOfCapitalizedProprietarySoftwareDevelopmentCostsIncludedInAccountsPayableAndOtherAccruedAndCurrentLiabilities	1647000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1444000	usd
CY2023	real	Tax Withholding Liability For Restricted Stock TaxWithholdingLiabilityForRestrictedStock	11000	usd
CY2022	real	Tax Withholding Liability For Restricted Stock TaxWithholdingLiabilityForRestrictedStock	11000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	14900000	usd
CY2021	real	Tax Withholding Liability For Restricted Stock TaxWithholdingLiabilityForRestrictedStock	3000	usd
CY2023	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made a presentation change to reclassify provision for inventory write-downs and shrinkage from inventory, net within operating cash flows in the statements of cash flows. Additionally, the Company has made a presentation change to the Company's statements of operations to reclassify its restructuring expenses from marketing, operations and technology, and sales, general and administrative operating expenses. Changes to reclassify amounts in the prior periods have been made to conform to the current period presentation.</span></div>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant items subject to such estimates and assumptions include those related to revenue recognition, including the returns reserve, standalone selling price related to consignment revenue transactions, valuation of inventory, software development costs, stock-based compensation, incremental borrowing rates related to lease liability, valuation of deferred taxes, and other contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span></div>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	48400000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	49000000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	46200000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175709000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	293793000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	418171000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	14914000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190623000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293793000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	418171000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	9800000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	4100000	usd
CY2023Q4	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	5200000	usd
CY2022Q4	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	6100000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	175709000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	293793000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	293793000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risks</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, restricted cash and accounts receivable. At times, such amount may exceed federally-insured limits. The Company is monitoring ongoing events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions or other companies in the financial services industry or the financial services industry generally. The Company reduces credit risk by placing its cash, cash equivalents, restricted cash and investments with major financial institutions with high credit ratings within the United States. The Company has not experienced any realized losses on cash, cash equivalents and restricted cash to date; however, no assurances can be provided.</span></div>As of December 31, 2023 and December 31, 2022, there were no customers that represented 10% or more of the Company’s accounts receivable balance and there were no customers that individually exceeded 10% of the Company’s total revenue for each of the years ended December 31, 2023, 2022, and 2021.
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	175709000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	178560000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	175814000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	74473000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	63135000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104087000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	112679000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31000000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26900000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23500000	usd
CY2023	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	8600000	usd
CY2022Q4	real	Accrued Returns Reserve Current AccruedReturnsReserveCurrent	22233000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	15111000	usd
CY2023Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	614000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	484000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8118000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8531000	usd
CY2023Q4	real	Site Credit And Gift Card Liability SiteCreditAndGiftCardLiability	14058000	usd
CY2022Q4	real	Site Credit And Gift Card Liability SiteCreditAndGiftCardLiability	13223000	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5012000	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	8729000	usd
CY2023Q4	real	Accrued Shipping AccruedShipping	4244000	usd
CY2022Q4	real	Accrued Shipping AccruedShipping	5715000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1166000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2214000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3549000	usd
CY2023Q4	real	Accrued Property And Equipment AccruedPropertyAndEquipment	1066000	usd
CY2022Q4	real	Accrued Property And Equipment AccruedPropertyAndEquipment	11417000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	3903000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	3134000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	82685000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	93292000	usd
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	25124423	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	21689051	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2022Q4	real	Aggregate Intrinsic Value Of Options Exercised AggregateIntrinsicValueOfOptionsExercised	5300000	usd
CY2021Q4	real	Aggregate Intrinsic Value Of Options Exercised AggregateIntrinsicValueOfOptionsExercised	20500000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.442
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.478
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.019
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.026
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	172000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	56000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	283000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	172000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34273000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	46138000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	48802000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	800000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1600000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1400000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	22800000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	29000000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	5200000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	5600000	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	31100000	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	700000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	26964000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	27787000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	27614000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	23608000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	20866000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	19866000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	146705000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	21755000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	124950000	usd
CY2023	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	34118000	usd
CY2022	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	27097000	usd
CY2021	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	25386000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6272000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2245000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	46614000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	283000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.061
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
CY2023	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	2	flagship_store
CY2023	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	2	neighborhood_store
CY2023	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	2	consignment_office
CY2023	us-gaap	Restructuring Charges RestructuringCharges	43500000	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	31100000	usd
CY2023	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	8600000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	3000000	usd
CY2023	us-gaap	Other Restructuring Costs OtherRestructuringCosts	1500000	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	700000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	7944000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	8344000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	4018000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	1158000	usd
CY2023Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	0	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	21464000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	56000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	283000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	172000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-35290000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-41209000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-49480000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-9554000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-11257000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-13704000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	8956000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	419000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2698000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	504000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	524000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3661000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	531000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	563000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	0	usd
CY2023	real	Effective Income Tax Rate Reconciliation Convertible Notes Amount EffectiveIncomeTaxRateReconciliationConvertibleNotesAmount	0	usd
CY2022	real	Effective Income Tax Rate Reconciliation Convertible Notes Amount EffectiveIncomeTaxRateReconciliationConvertibleNotesAmount	0	usd
CY2021	real	Effective Income Tax Rate Reconciliation Convertible Notes Amount EffectiveIncomeTaxRateReconciliationConvertibleNotesAmount	16782000	usd
CY2023	real	Effective Income Tax Reconciliation Adoption Of New Accounting Pronouncement EffectiveIncomeTaxReconciliationAdoptionOfNewAccountingPronouncement	0	usd
CY2022	real	Effective Income Tax Reconciliation Adoption Of New Accounting Pronouncement EffectiveIncomeTaxReconciliationAdoptionOfNewAccountingPronouncement	28045000	usd
CY2021	real	Effective Income Tax Reconciliation Adoption Of New Accounting Pronouncement EffectiveIncomeTaxReconciliationAdoptionOfNewAccountingPronouncement	0	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	9259000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	0	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	0	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	26501000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	80254000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	42327000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	438000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	49000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3168000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	283000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	172000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	232259000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	219872000	usd
CY2023Q4	real	Deferred Tax Assets Fixed Assets And Intangible Assets DeferredTaxAssetsFixedAssetsAndIntangibleAssets	6364000	usd
CY2022Q4	real	Deferred Tax Assets Fixed Assets And Intangible Assets DeferredTaxAssetsFixedAssetsAndIntangibleAssets	3904000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	13835000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	7899000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	12477000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	10867000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	840000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2474000	usd
CY2023Q4	real	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	33683000	usd
CY2022Q4	real	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	39143000	usd
CY2023Q4	real	Deferred Tax Assets Capped Calls DeferredTaxAssetsCappedCalls	15065000	usd
CY2022Q4	real	Deferred Tax Assets Capped Calls DeferredTaxAssetsCappedCalls	15082000	usd
CY2023Q4	real	Deferred Tax Assets Convertible Debt DeferredTaxAssetsConvertibleDebt	2329000	usd
CY2022Q4	real	Deferred Tax Assets Convertible Debt DeferredTaxAssetsConvertibleDebt	1675000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2569000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1416000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	319421000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	302332000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	292297000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	265796000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	27124000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	36536000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	24416000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	34330000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2708000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2206000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	27124000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	36536000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	26500000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	80300000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1525000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	531000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	563000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	622000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	962000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2678000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1525000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2700000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1500000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-168472000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-196445000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-236107000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101806000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101806000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95921246	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95921246	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91409624	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91409624	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.65
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.65
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.05
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.05
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.58
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.58
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32928249	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32565902	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31213281	shares
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.25
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	800000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1600000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1100000	usd

Files In Submission

Name	View Source	Status
R19.htm	Edgar Link	pending
0001573221-24-000030-index-headers.html	Edgar Link	pending
0001573221-24-000030-index.html	Edgar Link	pending
0001573221-24-000030.txt	Edgar Link	pending
0001573221-24-000030-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_1a.jpg	Edgar Link	pending
image_2a.jpg	Edgar Link	pending
image_3a.jpg	Edgar Link	pending
image_4a.jpg	Edgar Link	pending
image_5a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
real-20231231.htm	Edgar Link	pending
real-20231231.xsd	Edgar Link	pending
real-20231231xex1041.htm	Edgar Link	pending
real-20231231xex1042.htm	Edgar Link	pending
real-20231231xex1043.htm	Edgar Link	pending
real-20231231xex231.htm	Edgar Link	pending
real-20231231xex311.htm	Edgar Link	pending
real-20231231xex312.htm	Edgar Link	pending
real-20231231xex321.htm	Edgar Link	pending
real-20231231xex322.htm	Edgar Link	pending
real-20231231xex97.htm	Edgar Link	pending
real-20231231_g1.jpg	Edgar Link	pending
real-20231231_g2.jpg	Edgar Link	pending
real-20231231_g3.jpg	Edgar Link	pending
real-20231231_g4.jpg	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
real-20231231_cal.xml	Edgar Link	unprocessable
real-20231231_def.xml	Edgar Link	unprocessable
real-20231231_lab.xml	Edgar Link	unprocessable
real-20231231_pre.xml	Edgar Link	unprocessable
real-20231231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REAL
TheRealReal, Inc. Stock $real

2024 Q1 Form 10-K Financial Statement

#000157322124000030 Filed on March 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REAL TheRealReal, Inc. Stock $real

2024 Q1 Form 10-K Financial Statement

#000157322124000030 Filed on March 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REAL
TheRealReal, Inc. Stock $real